Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sponsors Should Disclose Trial Data Even During Development, JAMA Says

Executive Summary

Product sponsors need to publicly disclose more data about their products while they are in development in order to protect patients from unnecessary risk, authors of a study published April 28 in the Journal of the American Medical Association posit

You may also be interested in...



Public Citizen's FDA? Lurie Is Consumer Group's Third In Key Agency Role

FDA's appointment of a high-profile consumer advocate to an Office of the Commissioner post continues a strategy of bringing some of the most outspoken critics of both the drug industry and its regulatory agency into FDA

Lurie Moves To FDA, Becomes Third Public Citizen Staffer With Key Role

FDA's appointment of consumer advocate Peter Lurie to an Office of the Commissioner policy post suggests a strategy of bringing in some of the most outspoken critics of both the drug industry and FDA to address public perceptions of the agency

Public Citizen's FDA? Lurie Is Consumer Group's Third In Key Agency Role

FDA's appointment of a high-profile consumer advocate to an Office of the Commissioner post continues a strategy of bringing some of the most outspoken critics of both the drug industry and its regulatory agency into FDA

Related Content

Latest News
See All
UsernamePublicRestriction

Register

PS049598

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel